The series Advances in Stem Cell Biology is a timely and expansive collection of comprehensive information and new discoveries in the field of stem cell biology.
iPSCs for Modeling Central Nervous System Disorders, Volume 6 addresses how induced pluripotent stem cells can be used to model various CNS disorders.
Somatic cells can be reprogrammed into Induced pluripotent stem cells by the expression of specific transcription factors. These cells are transforming biomedical research in the last 15 years. The volume teaches readers about current advances in the field. This book describes the use of induced pluripotent stem cells to model several CNS diseases in vitro, enabling us to study the cellular and molecular mechanisms involved in different CNS pathologies. Further insights into these mechanisms will have important implications for our understanding of CNS disease appearance, development, and progression. In recent years, remarkable progress has been made in the obtention of induced pluripotent stem cells and their differentiation into several cell types, tissues and organs using state-of-art techniques. These advantages facilitated identification of key targets and definition of the molecular basis of several CNS disorders. This volume will cover what we know so far about the use of iPSCs to model different CNS disorders, such as: Alzheimer’s disease, Autism, Amyotrophic Lateral Sclerosis, Schizophrenia, Fragile X Syndrome, Spinal Muscular Atrophy, Rett Syndrome, Angelman syndrome, Parkinson`s Disease, Leber Hereditary Optic Neuropathy, Anorexia Nervosa, and more.
The volume is written for researchers and scientists interested in stem cell therapy, cell biology, regenerative medicine, and neuroscience; and is contributed by world-renowned authors in the field.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Advances in Stem Cell Biology - p. iii 6. Copyright - p. iii 7. Dedication - p. iii 8. Contributors - p. xv 9. About the editor - p. xviii 10. Preface - p. xxi 11. Chapter 1. In vitro human stem cell–mediated central nervous system platforms: progress and challenges - p. 1 12. Chapter 2. Human induced pluripotent stem cell– based modeling of Alzheimer’s disease, a glial perspective - p. 21 13. Chapter 3. Human induced pluripotent stem cell-based studies; a new route toward modeling autism spectrum disorders - p. 37 14. Chapter 4. Induced pluripotent stem cells as models for Amyotrophic Lateral Sclerosis - p. 83 15. Chapter 5. Induced pluripotent stem cells for modeling schizophrenia pathogenesis - p. 105 16. Chapter 6. Human pluripotent stem cells in the research of Fragile X Syndrome - p. 129 17. Chapter 7. Induced pluripotent stem cells for modeling of spinal muscular atrophy - p. 147 18. Chapter 8. Induced pluripotent stem cells for modeling of Rett Syndrome - p. 171 19. Chapter 9. Induced pluripotent stem cells for modeling Angelman syndrome - p. 217 20. Chapter 10. Induced pluripotent stem cells for modeling of X-linked dystonia-parkinsonism - p. 239 21. Chapter 11. Studying non–cell-autonomous neurodegeneration in Parkinson’s disease with induced pluripotent stem cells - p. 251 22. Chapter 12. Induced pluripotent stem cell–based leber hereditary optic neuropathy model - p. 277 23. Chapter 13. Investigating the pathophysiology of anorexia nervosa using induced pluripotent stem cells: background, current trends, and perspectives - p. 293 24. Index - p. 325
The series Advances in Stem Cell Biology is a timely and expansive collection of comprehensive information and new discoveries in the field of stem cell biology.
iPSCs for Modeling Central Nervous System Disorders, Volume 6 addresses how induced pluripotent stem cells can be used to model various CNS disorders.
Somatic cells can be reprogrammed into Induced pluripotent stem cells by the expression of specific transcription factors. These cells are transforming biomedical research in the last 15 years. The volume teaches readers about current advances in the field. This book describes the use of induced pluripotent stem cells to model several CNS diseases in vitro, enabling us to study the cellular and molecular mechanisms involved in different CNS pathologies. Further insights into these mechanisms will have important implications for our understanding of CNS disease appearance, development, and progression. In recent years, remarkable progress has been made in the obtention of induced pluripotent stem cells and their differentiation into several cell types, tissues and organs using state-of-art techniques. These advantages facilitated identification of key targets and definition of the molecular basis of several CNS disorders. This volume will cover what we know so far about the use of iPSCs to model different CNS disorders, such as: Alzheimer’s disease, Autism, Amyotrophic Lateral Sclerosis, Schizophrenia, Fragile X Syndrome, Spinal Muscular Atrophy, Rett Syndrome, Angelman syndrome, Parkinson`s Disease, Leber Hereditary Optic Neuropathy, Anorexia Nervosa, and more.
The volume is written for researchers and scientists interested in stem cell therapy, cell biology, regenerative medicine, and neuroscience; and is contributed by world-renowned authors in the field.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Advances in Stem Cell Biology - p. iii 6. Copyright - p. iii 7. Dedication - p. iii 8. Contributors - p. xv 9. About the editor - p. xviii 10. Preface - p. xxi 11. Chapter 1. In vitro human stem cell–mediated central nervous system platforms: progress and challenges - p. 1 12. Chapter 2. Human induced pluripotent stem cell– based modeling of Alzheimer’s disease, a glial perspective - p. 21 13. Chapter 3. Human induced pluripotent stem cell-based studies; a new route toward modeling autism spectrum disorders - p. 37 14. Chapter 4. Induced pluripotent stem cells as models for Amyotrophic Lateral Sclerosis - p. 83 15. Chapter 5. Induced pluripotent stem cells for modeling schizophrenia pathogenesis - p. 105 16. Chapter 6. Human pluripotent stem cells in the research of Fragile X Syndrome - p. 129 17. Chapter 7. Induced pluripotent stem cells for modeling of spinal muscular atrophy - p. 147 18. Chapter 8. Induced pluripotent stem cells for modeling of Rett Syndrome - p. 171 19. Chapter 9. Induced pluripotent stem cells for modeling Angelman syndrome - p. 217 20. Chapter 10. Induced pluripotent stem cells for modeling of X-linked dystonia-parkinsonism - p. 239 21. Chapter 11. Studying non–cell-autonomous neurodegeneration in Parkinson’s disease with induced pluripotent stem cells - p. 251 22. Chapter 12. Induced pluripotent stem cell–based leber hereditary optic neuropathy model - p. 277 23. Chapter 13. Investigating the pathophysiology of anorexia nervosa using induced pluripotent stem cells: background, current trends, and perspectives - p. 293 24. Index - p. 325
